M&A Deal Summary |
|
|---|---|
| Date | 2025-04-15 |
| Target | Theravia |
| Sector | Life Science |
| Buyer(s) | Norgine |
| Sellers(s) | Merieux Equity Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| Country: France M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-07 |
Endocuff
Leeds, United Kingdom ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2009 |
| PE ASSETS | 1.5B EUR |
| Size | Large |
| Type | Sector Focused |
Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Life Science M&A | 6 of 6 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| Country: France M&A | 5 of 5 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-03-21 |
curea medical
Steinfurt, Germany curea medical is a German manufacturer specializing in innovative wound care solutions, particularly superabsorbent dressings that enhance healing through superior fluid management. Leveraging the proprietary SuperCore technology, curea provides advanced products that significantly improve patient outcomes. The company serves homecare providers, pharmacies and hospitals. Its commitment to continuous growth, product innovation, and high-quality manufacturing has positioned curea as a key player in the advanced wound care sector. curea medical was founded in 2010 and is based in Steinfurt, Germany. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-04-29 |
Deepull
Barcelona, Spain Deepull develops rapid, affordable, and accessible diagnostic solutions from direct-to-blood pathogen detection to enable sepsis recognition in pre-symptomatic patients. Deepull was founded in 2020 and is based in Barcelona, Spain. |
Buy | - |
